These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 28770703)
1. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein. Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703 [TBL] [Abstract][Full Text] [Related]
2. Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders. Lee JH; Cho SB; Bang D; Oh SH; Ahn KJ; Kim J; Park YB; Lee SK; Lee KH Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S63-6. PubMed ID: 19796536 [TBL] [Abstract][Full Text] [Related]
3. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697 [TBL] [Abstract][Full Text] [Related]
4. Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity? Prado LL; Goncalves CR; Viana VT; Saad CGS; Bonfa E Clin Exp Rheumatol; 2018; 36(6 Suppl 115):28-32. PubMed ID: 29465373 [TBL] [Abstract][Full Text] [Related]
5. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
6. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease. Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E Front Immunol; 2021; 12():724900. PubMed ID: 35003055 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis. Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763 [TBL] [Abstract][Full Text] [Related]
8. Increased advanced oxidation protein products in Behçet's disease: a new activity marker? Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878 [TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations. Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507 [TBL] [Abstract][Full Text] [Related]
10. Serum anti-lysozyme is associated with disease activity of Behçet's disease. Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818 [TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease. Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281 [TBL] [Abstract][Full Text] [Related]
12. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease. Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175 [TBL] [Abstract][Full Text] [Related]
13. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement. Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013 [TBL] [Abstract][Full Text] [Related]
14. Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease. Shin SJ; Kim BC; Kim TI; Lee SK; Lee KH; Kim WH Dig Dis Sci; 2011 Mar; 56(3):812-8. PubMed ID: 20632102 [TBL] [Abstract][Full Text] [Related]
15. Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders. Cho SB; Lee JH; Ahn KJ; Cho S; Park YB; Lee SK; Bang D; Lee KH Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S31-8. PubMed ID: 20868568 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity. Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D modulates peripheral immunity in patients with Behçet's disease. Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571 [TBL] [Abstract][Full Text] [Related]
19. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters. Sarıyıldız MA; Yazmalar L; Batmaz İ; Alpaycı M; Burkan YK; Sula B; Kaplan İ; Yıldız M; Akar ZA; Bozkurt M Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990 [TBL] [Abstract][Full Text] [Related]
20. Streptococcus sanguinis and the sera of patients with Behçet's disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells. Cho S; Zheng Z; Cho SB; Choi MJ; Lee KH; Bang D Arch Dermatol Res; 2013 Apr; 305(3):223-32. PubMed ID: 23131860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]